David S. Hong, MD
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David S. Hong, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:24 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07155707 · Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical SettingsStanford University · recruiting · Anxiety, Mood Disorders
- N/ANCT06364137 · Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical SettingsStanford University · completed · Anxiety Disorders, Mood Disorders
- Ph1NCT05722327 · Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal CancerM.D. Anderson Cancer Center · active not recruiting · Colon Cancer, Colorectal Cancer · principal investigator
- Ph1NCT02942095 · Study of Ixazomib and Erlotinib in Solid TumorsM.D. Anderson Cancer Center · completed · Solid Tumors · principal investigator
- Ph1NCT02915172 · Lenvatinib and Capecitabine in Patients With Advanced MalignanciesM.D. Anderson Cancer Center · withdrawn · Advanced Cancer, Malignant Neoplasm of Breast, Malignant Neoplasms of Bone and Articular Cartilage · principal investigator
- Ph1NCT02668770 · Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid MalignanciesM.D. Anderson Cancer Center · terminated · Advanced Cancers, Melanoma · principal investigator
- Ph2NCT02478320 · Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid TumorsM.D. Anderson Cancer Center · terminated · Advanced Cancers · principal investigator
- Ph1NCT01744652 · Dasatinib and Crizotinib in Advanced CancerM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT01608139 · Study of Curcumin, Vorinostat, and SorafenibM.D. Anderson Cancer Center · withdrawn · Advanced Cancers · principal investigator
- Ph1NCT01454804 · Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid TumorsM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT01430572 · Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss PatientsM.D. Anderson Cancer Center · completed · Advanced Cancers, Solid Tumors
- Ph1NCT01201694 · Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)M.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT01113476 · Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesM.D. Anderson Cancer Center · completed · Advanced Cancer · study chair
- Ph1NCT01087554 · Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Cancer
- Ph1NCT00955812 · STAT3 Inhibitor for Solid TumorsM.D. Anderson Cancer Center · completed · Advanced Cancer, Solid Tumor · principal investigator
- Ph1NCT00554268 · Trial of PBI-05204 in Advanced Cancer PatientsM.D. Anderson Cancer Center · completed · Solid Tumors · principal investigator
- Ph1NCT00508807 · RTA 402 in Advanced Solid Tumors or Lymphoid MalignanciesM.D. Anderson Cancer Center · completed · Lymphoid Malignancies, Solid Tumors · principal investigator
- Ph1NCT00431054 · Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian CancerM.D. Anderson Cancer Center · completed · Ovarian Cancer · principal investigator
- Ph1NCT00429234 · Gemcitabine and Dasatinib in Advanced Solid TumorsM.D. Anderson Cancer Center · completed · Advanced Cancer, Solid Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Engagement and clinical impact of the Teleo virtual therapy platform in clinical settingsR42MH136878 · NIMH · MAINSQUARE CO · PI DAVID S HONG, Eric Roland Kuhn · fiscal years 2024 to 2026Named on NCT07155707, NCT06364137
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.